Express News | Sarepta: Co Will Nominate & Arrowhead Will Deliver Ind-Ready Constructs for 6 Targets Across Skeletal Muscle, Cardiac, CNS
Express News | Sarepta Therapeutics Inc - CEO Doug Ingram to Join Arrowhead Board
Express News | Sarepta Therapeutics Inc - Approves $500 Million Share Repurchase Authorization
Express News | Sarepta Therapeutics Inc - Arrowhead to Receive $500 Million Upfront and $325 Million Equity Investment
Express News | Sarepta Therapeutics Inc - Obtains Exclusive Licenses to Seven Programs
Express News | Sarepta Therapeutics Announces Global Licensing and Collaboration Agreement With Arrowhead Pharmaceuticals for Multiple Clinical and Preclinical Sirna Programs
